Clinical observation of patient with moya-moya syndrome complicated by transient ischemic attack followed by development of hemorrhagic stroke. Features of diagnosis and treatment

Author:

Tsibirova O. I.1ORCID,Privalova M. A.2ORCID,Sokolova M. G.3ORCID,Ulitin A. Yu.4ORCID,Privalova S. А.5ORCID,Tsibirov A. A.6ORCID,Belikova M. Ya.7ORCID

Affiliation:

1. Hospital for Veterans of Wars

2. Hospital for Veterans of Wars; North-Western State Medical University n. a. I. I. Mechnikov

3. North-Western State Medical University n. a. I. I. Mechnikov; Institute for Physiology n. a. I. P. Pavlov; Almazov National Medical Research Centre

4. North-Western State Medical University n. a. I. I. Mechnikov; Almazov National Medical Research Centre

5. Institute for Physiology n. a. I. P. Pavlov

6. All-Russian Centre for Emergency and Radiation Medicine n. a. A. M. Nikiforov

7. Hospital for Veterans of Wars; St. Petersburg Bekhterev Psychoneurological Research Institute

Abstract

Moya-moya syndrome is a chronic cerebrovascular disease associated with narrowing of the arteries of the brain, manifested by headache, epileptic seizures, transient ischemic attack, leading to the development of ischemic or hemorrhagic stroke. To date, the main pathogenetic mechanisms of moya-moya syndrome have not yet been fully identified, but some studies have shown that an important component of the development of moya-moya is a genetic factor. However, if the issue of diagnosis of this syndrome can be considered solved – it is the use of neuroimaging methods (MRI, CT) with contrast of cerebral vessels, then the issue of treatment remains relevant. The article presents a clinical case of a patient with moya-moya syndrome with the transformation of an ischemic stroke into a hemorrhagic type.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference23 articles.

1. Maksimova M. Yu. Clinical efficacy and antioxidant activity of Mildronate Russian Journal of Cardiology. 2009. No. 4 (78). Pp. 55–63.

2. Statsenko M. E., Turkina S. V., Lopushkova Yu. E. New data on a well-known drug: Focus on meldonium. Medical Counsil. 2021. No. 14. Pp. 44–51.

3. Sokolova M. G., Privalova M. A., et al. Clinical and laboratory rationale for the use of metabolic correctors for the treatment of patients with a new coronavirus infection COVID-19 in the acute period against the background of cerebrovascular disease. Medical Alphabet. Neurology and Psychiatry. 2022. No. 10 (2). Pp. 12–18. DOI: 10.33667/2078–5631–2022–10–12–16.

4. Fedin A. I., Solovyova E. Yu., Baranova O. A. Chronic cerebral ischemia and ischemic heart disease. Nervous Diseases. 2020. No. 3. Pp. 15–25.

5. Kheilo Yu.A., Danilogorskaya Yu.A., Nazarenko G. B. Indicators of bulbar capillaroscopy in CCI and ischemic heart disease. Therapy. 2020. No. 3 (37). Pp. 58–63.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3